ArticleOncotarget2017

Thalidezine, a novel AMPK activator, eliminates apoptosis-resistant cancer cells through energy-mediated autophagic cell death.

Betty Yuen Kwan Law et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.